Table 1.

Participants characteristics at 48 weeks on ART

Variable	Category	Frequency (%)
Outcome of participants	Completed	180 (70.3%)
	Lost to follow up	76 (29.6%)
Gender	Female	108 (60%)
	Male	72 (40%)
Age (years)	Median	39
	≤ 25 years	8 (4%)
	26 – 31 years	20 (11%)
	32–37 years	52 (29%)
	38–43 years	48 (27%)
	44–49 years	28 (16%)
	≥ 50 years	24 (13%)
ART regimen	EFV	100 (55.5%)
	NVP	80 (44.4%)

Abbreviations: ART Antiretroviral therapy, EFV Efavirenz, NVP Nevirapine